« Open source patent process | Main | Patents and financial markets »
March 5, 2007
Public-private non-patenting
From the blog Intellectual Property Watch -- NGO-Industry Drug For Poor Countries Sets Non-Patent Standard:
A new anti-malarial, non-patented drug available cheaply to the public sector is being hailed as proof that it is possible for the private and public sectors to overcome differences over patents and reach concrete results for public health in poor countries.
The not-for-profit research organisation, Drugs for Neglected Diseases initiative (DNDi), and the French pharmaceutical company, Sanofi-Aventis, are the partners behind the new drug, which soon will be available “non-patented for the public” in Sub-Saharan Africa and elsewhere, a DNDi spokesperson told Intellectual Property Watch.
There are a number of new models of collaborative research and IPR going on in medicine (see FasterCures - The Center for Accelerating Medical Solutions). The non-patent model is certainly one that should be explored further.
Posted by Ken Jarboe at March 5, 2007 11:38 AM
Trackback Pings
TrackBack URL for this entry:
http://www.athenaalliance.org/mt/mt-tb.cgi/1193